Transgender men and cervical cancer screening: what's holding them back?

NCT ID NCT05924217

Ongoing Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses a survey to understand why transgender men (people assigned female at birth who identify as male) in France may not get screened for cervical cancer. Researchers will ask 300 participants aged 25–65 about their screening history and what helps or hinders them. The goal is to identify barriers and solutions to make screening more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal specific obstacles and levers to improve cervical cancer screening rates among transgender men, helping reduce healthcare inequalities.
What could go wrong: This is an observational survey, not a treatment trial. It may not lead to immediate changes in screening programs, and results may not apply outside France.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HEALTH SERVICES FOR TRANSGENDER PERSONS TRANSGENDER PERSONS

Contacts and locations

Locations

CHU de Nîmes

Nîmes, 30900, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.